Skip to content
Kalpvruksh Markets
Offline Log in

PGHLNSEOffline

PROCTER&GAMBLE HEALT · INE199A01012 · Small Cap · #592
5,605.00−133.00 (−2.32%)last close · 05 Nov 2026
Prev close
5,738.00
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹8,925 cr
52-week range · to 05 Nov 20264,778.66,918.5

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

PGHL is 19% below its 52-week high, above its 200-day average — a Small Cap company, #592 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • above its 20 / 50 / 200-day averages · 19% below its 52-week high
  • −11.4% vs Nifty 500
  • traded value 3.5× usual · delivery 46% vs 56% usual
  • FPI +0.1 pp · DII +0.2 pp · MF schemes in Sept 2026: 10 bought, 2 cut · no promoter pledge · quarter ended 2026-09-30
  • nothing scheduled or restricting

How big is it?

six-month average market cap

Market capitalisation
₹8,925 cr
Rank
#592
Cap band
Small Cap
Nearest cut-off — Mid / Small
−73.90% from ₹34,190 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
0.6×
median 6,067
Delivered
3,661
Of volume
53%

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week+1.7%−4.0 pts—
1 month+5.6%+1.0 pts—
3 months−13.3%−11.4 pts—
6 months+5.0%+4.6 pts—
1 year−9.3%−6.8 pts—

Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
+4.9%
above
vs 50-day average
+2.7%
above
vs 200-day average
+0.4%
above
ATR (14)
4.5%
typical daily range
Volatility
41%
1 month, annualised
Beta
0.57
vs Nifty 500, 1 year
Traded value
3.5×
vs usual
Delivery
46%
usual 56%
From the 52-week high
−19.0%
place in range 39% (0 = at the low)

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters51.8%51.8%51.8%51.8%
FPI7.0%6.2% −0.86.3% +0.16.4% +0.1
Mutual funds10.5%10.2% −0.39.1% −1.18.9% −0.2
Other DII3.4%3.5% +0.13.4% −0.13.7% +0.3
Individuals22.4%23.2% +0.723.6% +0.423.3% −0.2
Others4.9%5.1% +0.25.8% +0.75.8% −0.1

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
none
Of all shares
none
Jun 25 noneSep 25 noneDec 25 noneMar 26 noneJun 26 noneSep 26 none

Holders

Sep 26

All shareholders
50,426
Individuals
46,321

Indian passive funds’ stake

2026-06-30

Of free float
0.00%
Of all shares
0.00%
Schemes
3
Days to unwind
<0.1
at 100% of volume

347 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
22
3 index · 19 active
Bought more
5
Sold some
3
FundSharesChangeDid
Tata India Pharma & Healthcare Fund-Reg(G)Active+23,277+130.4%bought
Aditya Birla SL MNC Fund-Reg(G)Active+15,000+18.8%bought
Nippon India Small Cap Fund(G)Active+2,000+0.3%bought
ICICI Pru Small Cap Fund(G)Active−2,80,264−76.8%sold
UTI MNC Fund-Reg(IDCW)Active−15,000−6.5%sold

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 26275520+2.3%₹822 cr
Aug 26222311+0.9%₹833 cr
Jul 26211311−4.2%₹946 cr
Jun 26210141−4.6%₹946 cr
May 26221342−2.5%₹949 cr
Apr 26233430−5.0%₹838 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Procter & Gamble Health Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
    02 Nov 2026
  • Board outcome
    Procter & Gamble Health Limited has submitted to the Exchange, the financial results for the quarter ended June 30, 2026.
    06 Aug 2026
  • Board outcome
    Outcome of Board Meeting-XBRL PROCTER & GAMBLE HEALTH LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 26-May-2026 for Dividend
    31 Jul 2026
  • Board outcome
    Procter & Gamble Health Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
    27 May 2026
  • Board outcome
    Outcome of Board Meeting-XBRL PROCTER & GAMBLE HEALTH LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 26-May-2026 for Dividend
    27 May 2026

PGHL: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Corporate actions

full published history

0 selected
RecentDividend₹45Final27 Aug 202627 Aug 2026
EarlierDividend₹50Special12 Feb 202612 Feb 2026
EarlierDividend₹110Interim12 Feb 202612 Feb 2026
EarlierDividend₹45Final22 Aug 202522 Aug 2025
EarlierDividend₹80Interim21 Feb 202521 Feb 2025
EarlierDividend₹60Final28 Nov 202429 Nov 2024
EarlierDividend₹50Interim14 Feb 202414 Feb 2024
EarlierDividend₹150Special14 Feb 202414 Feb 2024
EarlierDividend₹50Final23 Nov 202324 Nov 2023
EarlierDividend₹50Final13 Nov 202315 Nov 2023

15 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.